Wave Neuroscience Acquires Assets of NeoSync
In addition, Wave Neuroscience has acquired the Neuro-EEG Synchronization Therapy (NEST®) system developed and tested by NeoSync.
January 27, 2024
ACQUISITIONS and MERGERS
Medical Device News Magazine is the leading resource for medical device M&A information. We provide coverage of all the latest deals, as well as insights and analyses from industry experts.
Our readers rely on us for the most up-to-date information on the medical device market. We are focused on delivering the most comprehensive news coverage possible. Whether you are a CEO, CFO, investor, or employee of a medical device company, MDNM is the source you can trust for all your merger and acquisition news.
Boston Scientific Announces Agreement to Acquire Axonics, Inc.
Boston Scientific expects to complete the transaction in the first half of 2024, subject to customary closing conditions.
January 8, 2024
E Tech Group Announces Brand Name Change of Recently Acquired System Integrator, E-Volve Systems
E Tech Group announces the immediate renaming of E-Volve Systems to E Tech Group, following their strategic acquisition on February 23, 2023, emphasizing a unified vision, expanded services, and enhanced client and market value through this integration.
January 2, 2024
Allentown LLC Announces the Acquisition of ClorDiSys
ClorDiSys is a family-owned and operated company that began in 2001 as a decontamination equipment provider but quickly added surface-top disinfection products, as well as on-site decontamination services to its portfolio to better address customer challenges
December 28, 2023
ACQUISITIONS and MERGERS
TekniPlex Healthcare Acquires Seisa Medical
Based in El Paso, Texas, Seisa is a medical device manufacturer servicing every stage of the product life cycle including design and development, component manufacturing, and final assembly. It employs more than 2,000 people across four facilities in the U.S., Mexico and Slovakia.
December 19, 2023
Lunit to Acquire Volpara: Scheme Implementation Agreement Signed
Following the decision, Lunit and Volpara have entered into a Scheme Implementation Agreement, under which Lunit will acquire all of Volpara’s shares at a price of AUD 1.15 per share through a New Zealand scheme of arrangement (Scheme).
December 14, 2023
